Greenwich LifeSciences, Inc. (GLSI)

14.17 (USD) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017
Revenue Numbers are in millions	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.004	0.004	0.004	0.004	0.004	0.004	0.004
Gross Profit Numbers are in millions	-0.004	-0.004	-0.004	-0.004	-0.004	-0.004	-0.004
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	7.699	6.476	3.56	1.058	2.606	1.27	1.223
General & Administrative Expenses Numbers are in millions	1.629	1.565	1.038	0.806	0.819	0.42	0
Selling & Marketing Expenses Numbers are in millions	-0.004	0	0	0	0	0	0
SG&A Numbers are in millions	1.626	1.565	1.038	0.806	0.819	0.42	0.347
Other Expenses Numbers are in millions	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	9.324	8.04	4.598	1.864	3.425	1.69	1.57
Operating Income Numbers are in millions	-9.328	-8.04	-4.598	-1.864	-3.425	-1.69	-1.573
Operating Income Ratio Numbers are in millions	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0.436	0.215	0.027	0.001	0	0	0
Income Before Tax Numbers are in millions	-8.892	-7.825	-4.571	-1.863	-3.425	-1.69	-1.573
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	-0	-0.215	-0.027	-0.001	0	-0.158	0
Net Income Numbers are in millions	-8.892	-7.61	-4.543	-1.862	-3.425	-1.69	-1.573
Net Income Ratio Numbers are in millions	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.69	-0.59	-0.35	-0.15	-0.29	-0.14	-0.13
EPS Diluted Numbers are in millions	-0.69	-0.59	-0.35	-0.15	-0.29	-0.14	-0.13
EBITDA Numbers are in millions	-9.324	-8.037	-4.594	-1.86	-3.422	-1.686	-1.57
EBITDA Ratio Numbers are in millions	0	0	0	0	0	0	0

Greenwich LifeSciences, Inc.